Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

Blood pressure level impacts risk of death among HIV seropositive adults in Kenya: a retrospective analysis of electronic health records

Authors: Gerald S Bloomfield, Joseph W Hogan, Alfred Keter, Thomas L Holland, Edwin Sang, Sylvester Kimaiyo, Eric J Velazquez

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

Mortality among people with human immunodeficiency virus (HIV) infection is increasingly due to non-communicable causes. This has been observed mostly in developed countries and the routine care of HIV infected individuals has now expanded to include attention to cardiovascular risk factors. Cardiovascular risk factors such as high blood pressure are often overlooked among HIV seropositive (+) individuals in sub-Saharan Africa. We aimed to determine the effect of blood pressure on mortality among HIV+ adults in Kenya.

Methods

We performed a retrospective analysis of electronic medical records of a large HIV treatment program in western Kenya between 2005 and 2010. All included individuals were HIV+. We excluded participants with AIDS, who were <16 or >80 years old, or had data out of acceptable ranges. Missing data for key covariates was addressed by inverse probability weighting. Primary outcome measures were crude mortality rate and mortality hazard ratio (HR) using Cox proportional hazards models adjusted for potential confounders including HIV stage.

Results

There were 49,475 (74% women) HIV+ individuals who met inclusion and exclusion criteria. Mortality rates for men and women were 3.8 and 1.8/100 person-years, respectively, and highest among those with the lowest blood pressures. Low blood pressure was associated with the highest mortality incidence rate (IR) (systolic <100 mmHg IR 5.2 [4.8-5.7]; diastolic <60 mmHg IR 9.2 [8.3-10.2]). Mortality rate among men with high systolic blood pressure without advanced HIV (3.0, 95% CI: 1.6-5.5) was higher than men with normal systolic blood pressure (1.1, 95% CI: 0.7-1.7). In weighted proportional hazards regression models, men without advanced HIV disease and systolic blood pressure ≥140 mmHg carried a higher mortality risk than normotensive men (HR: 2.39, 95% CI: 0.94-6.08).

Conclusions

Although there has been little attention paid to high blood pressure among HIV+ Africans, we show that blood pressure level among HIV+ patients in Kenya is related to mortality. Low blood pressure carries the highest mortality risk. High systolic blood pressure is associated with mortality among patients whose disease is not advanced. Further investigation is needed into the cause of death for such patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Antiretroviral Therapy Cohort Collaboration: Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010, 50 (10): 1387-1396.CrossRef Antiretroviral Therapy Cohort Collaboration: Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010, 50 (10): 1387-1396.CrossRef
2.
go back to reference Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA: Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the infectious diseases society of America. Clin Infect Dis. 2014, 58 (1): e1-34. 10.1093/cid/cit665.CrossRefPubMed Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA: Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the infectious diseases society of America. Clin Infect Dis. 2014, 58 (1): e1-34. 10.1093/cid/cit665.CrossRefPubMed
3.
go back to reference Boccara F, Lang S, Meuleman C, Ederhy S, Mary-Krause M, Costagliola D, Capeau J, Cohen A: HIV and coronary heart disease: time for a better understanding. J Am Coll Cardiol. 2013, 61 (5): 511-523. 10.1016/j.jacc.2012.06.063.CrossRefPubMed Boccara F, Lang S, Meuleman C, Ederhy S, Mary-Krause M, Costagliola D, Capeau J, Cohen A: HIV and coronary heart disease: time for a better understanding. J Am Coll Cardiol. 2013, 61 (5): 511-523. 10.1016/j.jacc.2012.06.063.CrossRefPubMed
4.
go back to reference Ho JE, Scherzer R, Hecht FM, Maka K, Selby V, Martin JN, Ganz P, Deeks SG, Hsue PY: The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease. AIDS. 2012, 26 (9): 1115-1120. 10.1097/QAD.0b013e328352ce54.CrossRefPubMed Ho JE, Scherzer R, Hecht FM, Maka K, Selby V, Martin JN, Ganz P, Deeks SG, Hsue PY: The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease. AIDS. 2012, 26 (9): 1115-1120. 10.1097/QAD.0b013e328352ce54.CrossRefPubMed
5.
go back to reference Triant VA, Lee H, Hadigan C, Grinspoon SK: Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007, 92 (7): 2506-2512. 10.1210/jc.2006-2190.CrossRefPubMedPubMedCentral Triant VA, Lee H, Hadigan C, Grinspoon SK: Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007, 92 (7): 2506-2512. 10.1210/jc.2006-2190.CrossRefPubMedPubMedCentral
6.
go back to reference Friis-Møller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, Thiébaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, Lundgren JD, Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group: Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003, 349 (21): 1993-2003.CrossRefPubMed Friis-Møller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, Thiébaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, Lundgren JD, Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group: Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003, 349 (21): 1993-2003.CrossRefPubMed
7.
8.
go back to reference Joint United Nations Programme on HIV/AIDS (UNAIDS): World AIDS Day Report. 2012, Geneva: UNAIDS Joint United Nations Programme on HIV/AIDS (UNAIDS): World AIDS Day Report. 2012, Geneva: UNAIDS
9.
go back to reference Moore DM, Yiannoutsos CT, Musick BS, Tappero J, Degerman R, Campbell J, Were W, Kaharuza F, Alexander LN, Downing R, Mermim J: Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr. 2011, 58 (3): 289-296. 10.1097/QAI.0b013e3182303716.CrossRefPubMedPubMedCentral Moore DM, Yiannoutsos CT, Musick BS, Tappero J, Degerman R, Campbell J, Were W, Kaharuza F, Alexander LN, Downing R, Mermim J: Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr. 2011, 58 (3): 289-296. 10.1097/QAI.0b013e3182303716.CrossRefPubMedPubMedCentral
10.
go back to reference Gupta A, Nadkarni G, Yang W-T, Chandrasekhar A, Gupte N, Bisson GP, Hosseinipour M, Gummadi N: Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis. PLoS ONE. 2011, 6 (12): e28691-10.1371/journal.pone.0028691.CrossRefPubMedPubMedCentral Gupta A, Nadkarni G, Yang W-T, Chandrasekhar A, Gupte N, Bisson GP, Hosseinipour M, Gummadi N: Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis. PLoS ONE. 2011, 6 (12): e28691-10.1371/journal.pone.0028691.CrossRefPubMedPubMedCentral
11.
go back to reference Johnson LF, Mossong J, Dorrington RE, Schomaker M, Hoffmann CJ, Keiser O, Fox MP, Wood R, Prozesky H, Giddy J, Garone DB, Cornell M, Egger M, Boulle A, International Epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration: Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med. 2013, 10 (4): e1001418-10.1371/journal.pmed.1001418.CrossRefPubMedPubMedCentral Johnson LF, Mossong J, Dorrington RE, Schomaker M, Hoffmann CJ, Keiser O, Fox MP, Wood R, Prozesky H, Giddy J, Garone DB, Cornell M, Egger M, Boulle A, International Epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration: Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med. 2013, 10 (4): e1001418-10.1371/journal.pmed.1001418.CrossRefPubMedPubMedCentral
12.
go back to reference Bloomfield GS, Hogan JW, Keter A, Sang E, Carter EJ, Velazquez EJ, Kimaiyo S: Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya. PLoS ONE. 2011, 6 (7): e22288-10.1371/journal.pone.0022288.CrossRefPubMedPubMedCentral Bloomfield GS, Hogan JW, Keter A, Sang E, Carter EJ, Velazquez EJ, Kimaiyo S: Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya. PLoS ONE. 2011, 6 (7): e22288-10.1371/journal.pone.0022288.CrossRefPubMedPubMedCentral
13.
go back to reference Rabkin M, El-Sadr WM: Why reinvent the wheel? Leveraging the lessons of HIV scale-up to confront non-communicable diseases. Glob Public Hlth. 2011, 6 (3): 247-256. 10.1080/17441692.2011.552068.CrossRef Rabkin M, El-Sadr WM: Why reinvent the wheel? Leveraging the lessons of HIV scale-up to confront non-communicable diseases. Glob Public Hlth. 2011, 6 (3): 247-256. 10.1080/17441692.2011.552068.CrossRef
14.
go back to reference Einterz RM, Kimaiyo S, Mengech HNK, Khwa-Otsyula BO, Esamai F, Quigley F, Mamlin JJ: Responding to the HIV pandemic: the power of an academic medical partnership. Acad Med. 2007, 82 (8): 812-818. 10.1097/ACM.0b013e3180cc29f1.CrossRefPubMed Einterz RM, Kimaiyo S, Mengech HNK, Khwa-Otsyula BO, Esamai F, Quigley F, Mamlin JJ: Responding to the HIV pandemic: the power of an academic medical partnership. Acad Med. 2007, 82 (8): 812-818. 10.1097/ACM.0b013e3180cc29f1.CrossRefPubMed
15.
go back to reference Yiannoutsos CT, An M-W, Frangakis CE, Musick BS, Braitstein P, Wools-Kaloustian K, Ochieng D, Martin JN, Bacon MC, Ochieng V, Kimaiyo S: Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS ONE. 2008, 3 (12): e3843-10.1371/journal.pone.0003843.CrossRefPubMedPubMedCentral Yiannoutsos CT, An M-W, Frangakis CE, Musick BS, Braitstein P, Wools-Kaloustian K, Ochieng D, Martin JN, Bacon MC, Ochieng V, Kimaiyo S: Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS ONE. 2008, 3 (12): e3843-10.1371/journal.pone.0003843.CrossRefPubMedPubMedCentral
16.
go back to reference World Health Organization: WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2007, France: World Health Organization Press World Health Organization: WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2007, France: World Health Organization Press
17.
go back to reference Schneider E, Whitmore S, Glynn KM, Dominguez K, Mitsch A, McKenna MT, (CDC) CfDCaP: Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008. MMWR Recomm Rep. 2008, 57 (RR-10): 1-12.PubMed Schneider E, Whitmore S, Glynn KM, Dominguez K, Mitsch A, McKenna MT, (CDC) CfDCaP: Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008. MMWR Recomm Rep. 2008, 57 (RR-10): 1-12.PubMed
18.
go back to reference Robins J, Rotnitzky A, Zhao L: Estimation of regression coefficients when some regressors are not always observed. J Am Stat Assocv. 1994, 89 (427): 846-866. 10.1080/01621459.1994.10476818.CrossRef Robins J, Rotnitzky A, Zhao L: Estimation of regression coefficients when some regressors are not always observed. J Am Stat Assocv. 1994, 89 (427): 846-866. 10.1080/01621459.1994.10476818.CrossRef
19.
go back to reference Grinspoon SK, Grunfeld C, Kotler DP, Currier JS, Lundgren JD, Dubé MP, Lipshultz SE, Hsue PY, Squires K, Schambelan M, Wilson PWF, Yarasheski KE, Hadigan CM, Stein JH, Eckel RH: State of the science conference: initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Circulation. 2008, 118 (2): 198-210. 10.1161/CIRCULATIONAHA.107.189622.CrossRefPubMedPubMedCentral Grinspoon SK, Grunfeld C, Kotler DP, Currier JS, Lundgren JD, Dubé MP, Lipshultz SE, Hsue PY, Squires K, Schambelan M, Wilson PWF, Yarasheski KE, Hadigan CM, Stein JH, Eckel RH: State of the science conference: initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Circulation. 2008, 118 (2): 198-210. 10.1161/CIRCULATIONAHA.107.189622.CrossRefPubMedPubMedCentral
20.
go back to reference Muronya W, Sanga E, Talama G, Kumwenda JJ, van Oosterhout JJ: Cardiovascular risk factors in adult Malawians on long-term antiretroviral therapy. Trans R Soc Trop Med Hyg. 2011, 105 (11): 644-649. 10.1016/j.trstmh.2011.07.016.CrossRefPubMed Muronya W, Sanga E, Talama G, Kumwenda JJ, van Oosterhout JJ: Cardiovascular risk factors in adult Malawians on long-term antiretroviral therapy. Trans R Soc Trop Med Hyg. 2011, 105 (11): 644-649. 10.1016/j.trstmh.2011.07.016.CrossRefPubMed
21.
go back to reference Meya DB, Katabira E, Otim M, Ronald A, Colebunders R, Njama D, Mayanja-Kizza H, Whalen CC, Sande M: Functional adrenal insufficiency among critically ill patients with human immunodeficiency virus in a resource-limited setting. Afr Health Sci. 2007, 7 (2): 101-107.PubMedPubMedCentral Meya DB, Katabira E, Otim M, Ronald A, Colebunders R, Njama D, Mayanja-Kizza H, Whalen CC, Sande M: Functional adrenal insufficiency among critically ill patients with human immunodeficiency virus in a resource-limited setting. Afr Health Sci. 2007, 7 (2): 101-107.PubMedPubMedCentral
22.
go back to reference Marchetti G, Bellistrì GM, Borghi E, Tincati C, Ferramosca S, La Francesca M, Morace G, Gori A, Monforte AD: Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS. 2008, 22 (15): 2035-2038. 10.1097/QAD.0b013e3283112d29.CrossRefPubMed Marchetti G, Bellistrì GM, Borghi E, Tincati C, Ferramosca S, La Francesca M, Morace G, Gori A, Monforte AD: Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS. 2008, 22 (15): 2035-2038. 10.1097/QAD.0b013e3283112d29.CrossRefPubMed
23.
go back to reference Compostella C, Compostella L, D'Elia R: The symptoms of autonomic dysfunction in HIV-positive Africans. Clin Auton Res. 2008, 18 (1): 6-12. 10.1007/s10286-007-0451-y.CrossRefPubMed Compostella C, Compostella L, D'Elia R: The symptoms of autonomic dysfunction in HIV-positive Africans. Clin Auton Res. 2008, 18 (1): 6-12. 10.1007/s10286-007-0451-y.CrossRefPubMed
24.
go back to reference Okeahialam BN, Sani MU: Heart disease in HIV/AIDS. How much is due to cachexia?. Afr J Med Med Sci. 2006, 35 (Suppl): 99-102.PubMed Okeahialam BN, Sani MU: Heart disease in HIV/AIDS. How much is due to cachexia?. Afr J Med Med Sci. 2006, 35 (Suppl): 99-102.PubMed
25.
go back to reference Mateen FJ, Kanters S, Kalyesubula R, Mukasa B, Kawuma E, Kengne AP, Mills EJ: Hypertension prevalence and Framingham risk score stratification in a large HIV-positive cohort in Uganda. J Hypertens. 2013, 31 (7): 1372-1378. 10.1097/HJH.0b013e328360de1c. discussion 1378CrossRefPubMed Mateen FJ, Kanters S, Kalyesubula R, Mukasa B, Kawuma E, Kengne AP, Mills EJ: Hypertension prevalence and Framingham risk score stratification in a large HIV-positive cohort in Uganda. J Hypertens. 2013, 31 (7): 1372-1378. 10.1097/HJH.0b013e328360de1c. discussion 1378CrossRefPubMed
26.
go back to reference Seaberg EC, Muñoz A, Lu M, Detels R, Margolick JB, Riddler SA, Williams CM, Phair JP, Study MAC: Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS. 2005, 19 (9): 953-960. 10.1097/01.aids.0000171410.76607.f8.CrossRefPubMed Seaberg EC, Muñoz A, Lu M, Detels R, Margolick JB, Riddler SA, Williams CM, Phair JP, Study MAC: Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS. 2005, 19 (9): 953-960. 10.1097/01.aids.0000171410.76607.f8.CrossRefPubMed
27.
go back to reference Hsue PY, Hunt PW, Ho JE, Farah HH, Schnell A, Hoh R, Martin JN, Deeks SG, Bolger AF: Impact of HIV infection on diastolic function and left ventricular mass. Circ Heart Fail. 2010, 3 (1): 132-139. 10.1161/CIRCHEARTFAILURE.109.854943.CrossRefPubMed Hsue PY, Hunt PW, Ho JE, Farah HH, Schnell A, Hoh R, Martin JN, Deeks SG, Bolger AF: Impact of HIV infection on diastolic function and left ventricular mass. Circ Heart Fail. 2010, 3 (1): 132-139. 10.1161/CIRCHEARTFAILURE.109.854943.CrossRefPubMed
28.
go back to reference Hsue PY, Giri K, Erickson S, MacGregor JS, Younes N, Shergill A, Waters DD: Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation. 2004, 109 (3): 316-319. 10.1161/01.CIR.0000114520.38748.AA.CrossRefPubMed Hsue PY, Giri K, Erickson S, MacGregor JS, Younes N, Shergill A, Waters DD: Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation. 2004, 109 (3): 316-319. 10.1161/01.CIR.0000114520.38748.AA.CrossRefPubMed
29.
go back to reference Boccara F, Mary-Krause M, Teiger E, Lang S, Lim P, Wahbi K, Beygui F, Milleron O, Gabriel Steg P, Funck-Brentano C, Slama M, Girard P-M, Costagliola D, Cohen A, Prognosis of Acute Coronary Syndrome in HIV-infected patients (PACS) Investigators: Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis. Eur Heart J. 2011, 32 (1): 41-50. 10.1093/eurheartj/ehq372.CrossRefPubMed Boccara F, Mary-Krause M, Teiger E, Lang S, Lim P, Wahbi K, Beygui F, Milleron O, Gabriel Steg P, Funck-Brentano C, Slama M, Girard P-M, Costagliola D, Cohen A, Prognosis of Acute Coronary Syndrome in HIV-infected patients (PACS) Investigators: Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis. Eur Heart J. 2011, 32 (1): 41-50. 10.1093/eurheartj/ehq372.CrossRefPubMed
30.
go back to reference Nyabera R, Yonga G, Mwangemi F, Bukachi F: Evaluation of a project integrating cardiovascular care into HIV programmes. Cardiovasc J Afr. 2011, 22 (3): S17- Nyabera R, Yonga G, Mwangemi F, Bukachi F: Evaluation of a project integrating cardiovascular care into HIV programmes. Cardiovasc J Afr. 2011, 22 (3): S17-
31.
go back to reference Chillo P, Bakari M, Lwakatare J: Echocardiographic diagnoses in HIV-infected patients presenting with cardiac symptoms at Muhimbili National Hospital in Dar es Salaam, Tanzania. Cardiovasc J Afr. 2012, 23 (2): 90-97. 10.5830/CVJA-2011-060.CrossRefPubMedPubMedCentral Chillo P, Bakari M, Lwakatare J: Echocardiographic diagnoses in HIV-infected patients presenting with cardiac symptoms at Muhimbili National Hospital in Dar es Salaam, Tanzania. Cardiovasc J Afr. 2012, 23 (2): 90-97. 10.5830/CVJA-2011-060.CrossRefPubMedPubMedCentral
32.
go back to reference Schwartz T, Girgis M, Steen TW, Sjaasatd I: HIV as a risk factor for cardiac disease in Botswana: a cross-sectional study. Cardiovasc J Afr. 2011, 22 (3): S23- Schwartz T, Girgis M, Steen TW, Sjaasatd I: HIV as a risk factor for cardiac disease in Botswana: a cross-sectional study. Cardiovasc J Afr. 2011, 22 (3): S23-
33.
go back to reference Sani MU, Muhammad S, Okeahialam BN: Effects of HAART on cardiovascular risk profile of HIV/AIDS patients in Aminu Kano Teaching Hospital, Kano, Nigeria. Cardiovasc J Afr. 2011, 22 (3): S22- Sani MU, Muhammad S, Okeahialam BN: Effects of HAART on cardiovascular risk profile of HIV/AIDS patients in Aminu Kano Teaching Hospital, Kano, Nigeria. Cardiovasc J Afr. 2011, 22 (3): S22-
34.
go back to reference Dillon DG, Gurdasani D, Riha J, Ekoru K, Asiki G, Mayanja BN, Levitt NS, Crowther NJ, Nyirenda M, Njelekela M, Ramaiya K, Nyan O, Adewole OO, Anastos K, Azzoni L, Boom WH, Compostella C, Dave JA, Dawood H, Erikstrup C, Fourie CM, Friis H, Kruger A, Idoko JA, Longenecker CT, Mbondi S, Mukaya JE, Mutimura E, Ndhlovu CE: Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. Int J Epidemiol. 2013, 42: 1754-1771. 10.1093/ije/dyt198.CrossRefPubMed Dillon DG, Gurdasani D, Riha J, Ekoru K, Asiki G, Mayanja BN, Levitt NS, Crowther NJ, Nyirenda M, Njelekela M, Ramaiya K, Nyan O, Adewole OO, Anastos K, Azzoni L, Boom WH, Compostella C, Dave JA, Dawood H, Erikstrup C, Fourie CM, Friis H, Kruger A, Idoko JA, Longenecker CT, Mbondi S, Mukaya JE, Mutimura E, Ndhlovu CE: Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. Int J Epidemiol. 2013, 42: 1754-1771. 10.1093/ije/dyt198.CrossRefPubMed
35.
go back to reference Alibhai A, Kipp W, Saunders LD, Senthilselvan A, Kaler A, Houston S, Konde-Lule J, Okech-Ojony J, Rubaale T: Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda. Int J Womens Health. 2010, 2: 45-52.CrossRefPubMedPubMedCentral Alibhai A, Kipp W, Saunders LD, Senthilselvan A, Kaler A, Houston S, Konde-Lule J, Okech-Ojony J, Rubaale T: Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda. Int J Womens Health. 2010, 2: 45-52.CrossRefPubMedPubMedCentral
36.
go back to reference Oti SO, Mutua M, Mgomella GS, Egondi T, Ezeh A, Kyobutungi C: HIV mortality in urban slums of Nairobi, Kenya 2003-2010: a period effect analysis. BMC Public Health. 2013, 13: 588-10.1186/1471-2458-13-588.CrossRefPubMedPubMedCentral Oti SO, Mutua M, Mgomella GS, Egondi T, Ezeh A, Kyobutungi C: HIV mortality in urban slums of Nairobi, Kenya 2003-2010: a period effect analysis. BMC Public Health. 2013, 13: 588-10.1186/1471-2458-13-588.CrossRefPubMedPubMedCentral
37.
go back to reference Byass P, Calvert C, Miiro-Nakiyingi J, Lutalo T, Michael D, Crampin A, Gregson S, Takaruza A, Robertson L, Herbst K, Todd J, Zaba B: InterVA-4 as a public health tool for measuring HIV/AIDS mortality: a validation study from five African countries. Glob Health Act. 2013, 6: 22448- Byass P, Calvert C, Miiro-Nakiyingi J, Lutalo T, Michael D, Crampin A, Gregson S, Takaruza A, Robertson L, Herbst K, Todd J, Zaba B: InterVA-4 as a public health tool for measuring HIV/AIDS mortality: a validation study from five African countries. Glob Health Act. 2013, 6: 22448-
Metadata
Title
Blood pressure level impacts risk of death among HIV seropositive adults in Kenya: a retrospective analysis of electronic health records
Authors
Gerald S Bloomfield
Joseph W Hogan
Alfred Keter
Thomas L Holland
Edwin Sang
Sylvester Kimaiyo
Eric J Velazquez
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-284

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.